{
    "title": "Bayer's Nubeqa drug significantly prolongs survival in prostate cancer trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10525183/Bayers-Nubeqa-drug-significantly-prolongs-survival-prostate-cancer-trial.html",
    "date": "2022-02-17",
    "keywords": [
        "therapy",
        "drug",
        "bayer",
        "cancer",
        "prostate",
        "trial",
        "company",
        "burger",
        "patricia",
        "frankfurt",
        "mix",
        "study",
        "risk",
        "period",
        "comparison",
        "statement",
        "darolutamide",
        "drugmaker",
        "orion",
        "hormone",
        "point",
        "market",
        "opportunity",
        "wider",
        "use",
        "weedkiller",
        "development",
        "pipeline",
        "prevention",
        "pill",
        "eye",
        "eylea",
        "decline",
        "industry",
        "kidney",
        "disease",
        "treatment",
        "finerenone",
        "menopausal",
        "relief",
        "success",
        "december",
        "journal",
        "medicine",
        "thursday",
        "editing",
        "miranda",
        "murray"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}